Latest Breaking News On - Investigational cancer therapeutics - Page 1 : vimarsana.com

Bile Duct Cancer Continues to Respond to Zanidatamab, Per Longer Follow-Up

Zanidatamab continued to lead to responses and improved overall survival in pretreated HER2-positive biliary tract cancer.

United statesDepartment of gastrointestinal medical oncologyUniversity of texas md anderson cancer centerShubham pantGastrointestinal medical oncologyInvestigational cancer therapeuticsPhasei centerCancer center

Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors

Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The University of Texas MD Anderson Cancer Center demonstrate promising responses and safety profiles in heavily pretreated patients with advanced solid tumors.

United statesScott kopetzTimothy yapUniversity of texas md anderson cancer centerAmerican society of clinical oncologyClinical oncologyAnnual meetingCancer centerGastrointestinal medical oncologyInvestigational cancer therapeuticsTherapeutics discoveryFanconi anemia

Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings,.

United statesKristin bhavnaniMohamedtaki abdulaziz tejaniHye jin choiJean phillippe metgesNobuyoshi hiraokaAndrean flynnRob iannoneAsia pacificEuropean medicines agencyJazz pharmaceuticalsDepartment of gastrointestinal medical oncologyBeigene ltdExchange commissionCommission file noAmerican society of clinical oncology

ASCO: New Targeted Therapies Prove Safe, Active in Metastatic Tumors

ASCO: New Targeted Therapies Prove Safe, Active in Metastatic Tumors
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy yapScott kopetzPhasei researchUniversity of texas md anderson cancer centerAmerican society of clinical oncologySerono research development institute incClinical oncologyAnnual meetingCancer centerGastrointestinal medical oncologyDevelopment instituteInvestigational cancer therapeuticsTherapeutics discoveryFanconi anemiaInvestigational cancer

Dr Yap on the Continued Investigation of Saruparib in Advanced Solid Tumors

Dr Yap on the Continued Investigation of Saruparib in Advanced Solid Tumors
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy yapDepartment of thoracic headTherapeutics discovery divisionKhalifa institute for personalized cancer therapyUniversity of texas md anderson cancer centerInvestigational cancer therapeuticsPhasei programNeck medical oncologyKhalifa institutePersonalized cancer therapyCancer center